Status:
RECRUITING
Mechanisms of Multi-organ Failure in COVID-19
Lead Sponsor:
Imperial College London
Conditions:
COVID
Eligibility:
All Genders
18-90 years
Brief Summary
In the United Kingdom, there are currently 138,000 confirmed patients with coronavirus, causing 18,738 deaths. Whilst the disease may be mild in the majority of patients, a significant proportion of p...
Detailed Description
COVID-19 is a highly contagious virus, causing a global health emergency. A significant number (\~17%) of hospitalised patients become severely unwell and require admission to an intensive care unit (...
Eligibility Criteria
Inclusion
- Male and female patients aged 18-90 years;
- Patients diagnosed with COVID-19 and without COVID-19 (control purposes);
- Patients who have developed evidence of organ injury failure (requiring oxygen).
Exclusion
- Patients who are under the age of 18;
- Refusal to consent/gain assent;
- Presence of an advanced directive to withhold or to withdraw life-sustaining treatment;
- Moribund patient likely to die within 24 hours.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04399603
Start Date
June 1 2020
End Date
December 31 2024
Last Update
March 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom
2
Imperial College NHS Trust
London, United Kingdom